comparemela.com
Home
Live Updates
Mukul Bhattarai - Breaking News
Pages:
Mukul Bhattarai News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Groups
A comprehensive meta-analysis finds cardiovascular improvement across age, sex, and race/ethnicity for high-risk individuals with type 2 diabetes and other CVD risk factors.
United states
Southern illinois university
Mukul bhattarai
Southern illinois university school of medicine
Southern illinois university school
Consistent cardiovascular benefits
Seen across age
Ethnicity subgroups
Heart failure
Sglt2 inhibitors
Odium glucose transporter 2 inhibitors
Odium glucose co transporter 2 inhibitors
Sodium glucose cotransporter 2 inhibitors
Diabetes mellitus type 2
Iabetes mellitus type ii
Type 2 diabetes
vimarsana © 2020. All Rights Reserved.